Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients.
about
Purine analogues plus cyclophosphamide versus purine analogues alone for first-line therapy of patients with chronic lymphocytic leukaemiaPulmonary vasculitisPharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide-treated ratsPharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis - comparison of the effects of dexamethasone and MesnaAlterations in spinal cord Fos protein expression induced by bladder stimulation following cystitisInvolvement of nitric oxide in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitisChemotherapy-related complications in the kidneys and collecting system: an imaging perspective.Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer.The safety profile of cyclophosphamide in multiple sclerosis therapy.Endogenous nerve growth factor regulates collagen expression and bladder hypertrophy through Akt and MAPK pathways during cystitis.Encouraging results in the treatment of haemorrhagic cystitis with estrogen - report of 10 cases and review of the literature.Hemorrhagic cystitis: A challenge to the urologist.Erythropoietin in stem cell transplantation.Lights and shadows of cyclophosphamide in the treatment of multiple sclerosisPilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG)Iatrogenic changes in the urinary tract.Recent advances of cocktail chemotherapy by combination drug delivery systems.Urological implications of cyclophosphamide and ifosfamide.Chemotherapy-induced bladder cancer.The mouse cyclophosphamide model of bladder pain syndrome: tissue characterization, immune profiling, and relationship to metabotropic glutamate receptors.Low-dose cyclophosphamide associated with hemorrhagic cystitis in a breast cancer patient.Complications of oncologic therapy in the abdomen and pelvis: a review.Immunotherapy of HPV infection-caused genital warts using low dose cyclophosphamide.Divergent functions of the left and right central amygdala in visceral nociception.Pentostatin, Cyclophosphamide and Rituximab (PCR) Regimen.Furosemide for prevention of cyclophosphamide-associated sterile haemorrhagic cystitis in dogs receiving metronomic low-dose oral cyclophosphamide.Treatment of cyclophosphamide-induced hemorrhagic cystitis with prostaglandins.A case of severe hemorrhagic cystitis caused by melphalan with successful bladder preservation by ligation of bilateral internal iliac arteries.Urinary bladder cancer in Wegener's granulomatosis: is it more than cyclophosphamide?Renal cell carcinoma associated with cyclophosphamide therapy for Wegener's granulomatosis.Correlation of the clinical parameters with sonographic findings of hemorrhagic cystitis in pediatric hematooncology patients.Cyclophosphamide and the urinary tract.COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat.Cystitis-induced upregulation of tyrosine kinase (TrkA, TrkB) receptor expression and phosphorylation in rat micturition pathways.Cytomegalovirus-induced haemorrhagic cystitis in a patient with neurogenic bladder.Region-specific changes in the phosphorylation of ERK1/2 and ERK5 in rat micturition pathways following cyclophosphamide-induced cystitis.
P2860
Q24198941-54DAC834-7A16-4204-B89B-975A05CA44DFQ27477901-02CEC035-CF0A-44C3-98F2-F4CF47F9CCA0Q28343595-2F1FDAB2-94AE-41FA-A33F-92B2978E9B29Q28373556-EAD3C4C3-660A-43C5-883E-A79750F40654Q28375343-8A3B7C34-9884-4D2D-9AFC-88509146A8DDQ28379421-B7D41997-C4D6-4979-8167-37B9981FDA47Q30405427-2E975BC9-F123-4640-A732-181943DD8AEDQ30713680-BE78E7AF-5D07-46DB-8D29-0965824251EAQ31105891-674A7067-2CD5-4E75-98DB-E2FFF2861893Q33662383-5E122231-E4E8-49C6-BC15-FCE40E744C07Q33912044-C3CA5600-9C34-41B6-BA36-0D2D4DF8DCCDQ34123974-93EA4188-DA15-4112-9BA3-3716D08D05C1Q34299724-8E379462-5CBC-41FA-A721-B8F548569E18Q34922742-4B11C55E-6071-449F-89A7-925B0EC88498Q34999814-234C5408-67BD-49EF-BE77-1F556048A93CQ36222426-7B587B45-9612-46F9-BD99-1374E449EC76Q37206908-9750F6EE-156D-4024-83FA-4950C475BA2AQ37264407-53A04259-59B3-4311-9D31-0726244695CDQ37278978-FC972703-C718-4960-9349-50D19822DB1AQ37727892-9699801C-1EA1-4593-9BB2-042FFF0C26E5Q37942592-ED0D972A-A25D-4F69-BC73-917FD74DAC2AQ38014349-618D2D90-63EB-4CF4-847D-C63D15688822Q38211240-9C39029F-8505-41CB-B3C1-7FD14872EFD4Q38948220-3BD1EBF6-F9FB-4A3E-BF58-572CC9D78626Q39037182-57F02DC9-717E-488E-A485-D22A4D0B444BQ40337132-DAA3106E-CC19-44B3-9CF9-F9591E5EDE8DQ40693704-E895FEA1-0295-42A0-9DC2-064F47161BAFQ41479229-4A67D07E-9719-428F-9D8C-9200CDDA4085Q42161729-6D3D408F-7870-46AC-83FC-4F1CF1A6765DQ42551599-47C437DB-8485-404E-9FC2-52E1C8FB0151Q43194635-54D220B7-D2A6-40BB-B857-F55AD05D64AAQ44009974-661A3FC6-4AEA-4671-B268-6EE8ECF8DBB6Q44185849-495AF622-EC14-48CC-B608-AA775C45ACBCQ44202160-DE34D43A-E571-47E4-9FE4-8D7718CA2F4FQ44728031-C50274A3-0401-43AE-802C-70F623381CA2Q44924799-9F28AFD1-FFC3-43BF-9647-A51EB420A651
P2860
Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients.
@en
Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients.
@nl
type
label
Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients.
@en
Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients.
@nl
prefLabel
Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients.
@en
Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients.
@nl
P2860
P1433
P1476
Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients.
@en
P2093
Benson RC Jr
Stillwell TJ
P2860
P304
P356
10.1002/1097-0142(19880201)61:3<451::AID-CNCR2820610308>3.0.CO;2-G
P407
P577
1988-02-01T00:00:00Z